CureSearch Launches 2026 Community Impact Awards to Strengthen Psychosocial Support Systems for Pediatric Cancer Patients and Families
admin The national nonprofit organization CureSearch for Children’s Cancer has officially announced the launch of its...
admin
Unlocking Immunotherapy’s Full Potential: Dr. Karin Pelka Pioneers AI-Driven Approach to Conquer Colorectal Cancer
Colorectal cancer (CRC), encompassing both colon and rectal cancers, represents a formidable challenge in modern...
FDA Rejects Replimune’s Melanoma Therapy Again Citing Unaddressed Study Concerns, Fueling Industry Debate
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
Meet Macon, a 3 year old B-Cell Acute Lymphoblastic Leukemia warrior.
The clinical journey for Macon began not with an emergency room visit or a sudden...
Beyond the Milestone How Nathan Gray’s Legacy is Driving Breakthroughs in Pediatric Cancer Research
The start of a new school year is traditionally marked by a sense of renewal...
Lumanity’s Cancer Progress 2026: Confronting Oncology’s Future Challenges with Critical Insights and Strategic Shifts
Lumanity’s Cancer Progress 2026, held on April 9th at the New York Genome Center, served...
Advancing Pediatric Brain Cancer Treatment: Dr. Joshua Breunig Named 2024 CureSearch Acceleration Initiative Awardee for Breakthrough Glioma Research
The landscape of pediatric oncology is witnessing a significant shift as innovative genetic modeling and...
The Quest for Normalcy Pediatric Cancer Survivors Navigate the Complexities of Returning to School
As the school bells ring across the nation this fall, the transition back to the...
FDA Grants Accelerated Approval to OJEMDA for the Treatment of Relapsed or Refractory Pediatric Low-Grade Glioma
The United States Food and Drug Administration (FDA) has officially granted accelerated approval to OJEMDA...
Acceleration Initiative Award Empowers UCLA Research to Advance CAR T-Cell Therapy for Metastatic Ewing Sarcoma
In a significant move to address the stagnant survival rates of pediatric bone cancer, CureSearch...
